Skip to main content
logo
Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.049
-0.061 (-5.50%)
At close: Aug 14, 2026, 4:00 PM EDT
1.049
0.00 (0.04%)
After-hours: Aug 14, 2026, 7:42 PM EDT

Revelation Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.4810.76.511.995.251.27
Cash & Short-Term Investments
11.4810.76.511.995.251.27
Cash Growth
121.94%64.64%-45.80%128.28%312.09%-71.63%
Prepaid Expenses
0.20.050.070.080.070.64
Other Current Assets
-0.06-0.070.09-
Total Current Assets
11.6810.816.5712.155.411.91
Property, Plant & Equipment
0.780.740.060.070.090.13
Other Long-Term Assets
0.030.03----
Total Assets
12.511.586.6212.215.52.04
Accounts Payable
0.930.580.781.360.550.6
Accrued Expenses
0.761.41.131.150.991.53
Current Portion of Leases
0.190.02---0.02
Other Current Liabilities
---3.052.91-
Total Current Liabilities
1.8821.915.564.452.14
Long-Term Leases
0.550.72----
Total Liabilities
2.432.721.915.564.452.14
Common Stock
000000
Additional Paid-In Capital
65.8158.2845.2132.1126.414.42
Retained Earnings
-55.75-49.42-40.51-25.47-25.35-14.52
Total Common Equity
10.078.864.716.651.05-0.1
Shareholders' Equity
10.078.864.716.651.05-0.1
Total Liabilities & Equity
12.511.586.6212.215.52.04
Total Debt
0.740.75---0.02
Net Cash (Debt)
10.749.956.511.995.251.26
Net Cash Growth
107.64%53.15%-45.80%128.28%317.57%-72.00%
Net Cash Per Share
4.6516.03454.70---
Filing Date Shares Outstanding
3.983.720.08---
Total Common Shares Outstanding
3.911.580.04---
Working Capital
9.88.814.656.580.96-0.23
Book Value Per Share
2.585.59108.19---
Tangible Book Value
10.078.864.716.651.05-0.1
Tangible Book Value Per Share
2.585.59108.19---
Machinery
-0.120.150.130.130.13
SEC Filings: 10-K · 10-Q